Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 Diabetes
Clinical trial NCT01720303 · COMPLETED
Trial details
- NCT number
- NCT01720303
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-19
- Primary completion
- 2003-04-10
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.